Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (351-360 of 715) with videos related to

Pageof 72
Sort By:
The Journal of Biological Chemistry|March 25, 1990
Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu)H R Lijnen, B Van Hoef, L Nelles, et al.
Thrombosis and Haemostasis|April 8, 1991
Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasmaP J Declerck, H R Lijnen, M Verstreken, et al.
Blood|February 1, 1987
Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activatorD C Stump, J M Stassen, E Demarsin, et al.
Blood|April 1, 1989
Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbitsD J Spriggs, J M Stassen, Y Hashimoto, et al.
Thrombosis and Haemostasis|December 27, 1982
Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivoD Collen, D C Rijken, J Van Damme, et al.
Analytical Biochemistry|June 1, 1997
Screening panels of monoclonal antibodies using phage-displayed antigenH R Lijnen, I Lasters, M Verstreken, et al.
European Journal of Clinical Investigation|February 1, 1977
Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administrationD Collen, J Schetz, F de Cock, et al.
British Medical Journal (Clinical Research Ed.)|August 31, 1985
Plasminogen activator inhibitor in the blood of patients with coronary artery diseaseJ A Paramo, M Colucci, D Collen, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 25, 1999
A fully functional deletion staphylokinase derivative crystallizes in two non-isomorphous monoclinic modificationsA Rabijns, H L De Bondt, D Collen, et al.
Blood|March 26, 1999
Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleedingH R Lijnen, K Okada, O Matsuo, et al.
Pageof 72

Showing results (351-360 of 715) with videos related to

Sort By:
Pageof 72
The Journal of Biological Chemistry|March 25, 1990
Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu)H R Lijnen, B Van Hoef, L Nelles, et al.
Thrombosis and Haemostasis|April 8, 1991
Role of alpha 2-antiplasmin in fibrin-specific clot lysis with single-chain urokinase-type plasminogen activator in human plasmaP J Declerck, H R Lijnen, M Verstreken, et al.
Blood|February 1, 1987
Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activatorD C Stump, J M Stassen, E Demarsin, et al.
Blood|April 1, 1989
Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbitsD J Spriggs, J M Stassen, Y Hashimoto, et al.
Thrombosis and Haemostasis|December 27, 1982
Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivoD Collen, D C Rijken, J Van Damme, et al.
Analytical Biochemistry|June 1, 1997
Screening panels of monoclonal antibodies using phage-displayed antigenH R Lijnen, I Lasters, M Verstreken, et al.
European Journal of Clinical Investigation|February 1, 1977
Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administrationD Collen, J Schetz, F de Cock, et al.
British Medical Journal (Clinical Research Ed.)|August 31, 1985
Plasminogen activator inhibitor in the blood of patients with coronary artery diseaseJ A Paramo, M Colucci, D Collen, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 25, 1999
A fully functional deletion staphylokinase derivative crystallizes in two non-isomorphous monoclinic modificationsA Rabijns, H L De Bondt, D Collen, et al.
Blood|March 26, 1999
Alpha2-antiplasmin gene deficiency in mice is associated with enhanced fibrinolytic potential without overt bleedingH R Lijnen, K Okada, O Matsuo, et al.
Pageof 72